GGrantIndex
← Leaderboards

Yongmei Liu

Duke University

$27,829,496
Attributed
$42,486,268
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.3M · FY200625
$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$42,486,268 · 14

By mechanism

R01$36,709,792 · 10
RF1$4,132,612 · 1
R56$818,883 · 1
RC1$814,020 · 1
M01$10,961 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposParticipantMonocyteRisk FactorsCohortSamplingAtherosclerosisInsightPhenotypeGenesEpigenetic ProcessBaseMediatingCellsSignal TransductionGenomicsFollow-UpIn VitroObesityPlayTranscriptomicsPreventionInflammatoryGenetic

Grant awards (46)

Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)$4,677,012
R01 · FY2025 · AG
Common mechanistic biomarkers of vascular and neuro-degeneration$731,819
R01 · FY2025 · AG · contact PI
T helper cells in development of chronic inflammation and multimorbidity$601,436
R01 · FY2025 · AG
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)$4,759,428
R01 · FY2024 · AG
Common mechanistic biomarkers of vascular and neuro-degeneration$769,115
R01 · FY2024 · AG · contact PI
T helper cells in development of chronic inflammation and multimorbidity$626,628
R01 · FY2024 · AG
Common mechanistic biomarkers of vascular and neuro-degeneration$829,329
R01 · FY2023 · AG · contact PI
T helper cells in development of chronic inflammation and multimorbidity$661,842
R01 · FY2023 · AG
Trajectories of blood-based biomarkers of AD, their determinants, and ability to predict cognitive impairment$818,883
R56 · FY2022 · AG · contact PI
A Longitudinal Epigenetic Study of Atherosclerosis$1,309,468
R01 · FY2020 · HL · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$457,397
R01 · FY2020 · DK
A Longitudinal Epigenetic Study of Atherosclerosis$1,492,732
R01 · FY2019 · HL · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$654,447
R01 · FY2019 · DK
Obesity-Related Epigenetic Changes and Type-2 Diabetes$436,382
R01 · FY2019 · DK · contact PI
Cell-specific genomic features of Alzheimer's disease progression$387,500
RF1 · FY2019 · AG
A Longitudinal Epigenetic Study of Atherosclerosis$1,500,172
R01 · FY2018 · HL · contact PI
Obesity-related epigenetic changes and type-2 diabetes$646,075
R01 · FY2018 · DK · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$644,740
R01 · FY2018 · DK
miRNA Epigenetic Roles in Regulations of Cholesterol Metabolism and CVD Risk$409,953
R01 · FY2018 · HL · contact PI
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$336,656
R01 · FY2018 · HL · contact PI
Cell-specific genomic features of Alzheimer's disease progression$3,745,112
RF1 · FY2017 · AG
A Longitudinal Epigenetic Study of Atherosclerosis$1,497,682
R01 · FY2017 · HL · contact PI
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$746,222
R01 · FY2017 · HL · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$663,562
R01 · FY2017 · DK
Obesity-related epigenetic changes and type-2 diabetes$651,436
R01 · FY2017 · DK · contact PI
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$764,754
R01 · FY2016 · HL · contact PI
Obesity-related epigenetic changes and type-2 diabetes$742,998
R01 · FY2016 · DK · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$661,862
R01 · FY2016 · DK
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$785,637
R01 · FY2015 · HL · contact PI
Obesity-related epigenetic changes and type-2 diabetes$690,448
R01 · FY2015 · DK · contact PI
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis$687,401
R01 · FY2013 · HL · contact PI
Genetic Determinants of Visceral Adiposity$506,110
R01 · FY2013 · AG · contact PI
Genetic Determinants of Visceral Adiposity$832,615
R01 · FY2012 · AG · contact PI
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis$715,940
R01 · FY2012 · HL · contact PI
Genetic Determinants of Visceral Adiposity$755,218
R01 · FY2011 · AG · contact PI
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis$731,493
R01 · FY2011 · HL · contact PI
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis$754,658
R01 · FY2010 · HL · contact PI
Genetic Determinants of Visceral Adiposity$685,217
R01 · FY2010 · AG · contact PI
Discovering Pathways of Functional Decline: A GWAS Approach$398,445
RC1 · FY2010 · AG
DNA METHYLATION AND GENE EXPRESSION PROFILES IN MONOCYTES$10,961
M01 · FY2010 · RR · contact PI
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis$734,646
R01 · FY2009 · HL · contact PI
Genetic Determinants of Visceral Adiposity$612,785
R01 · FY2009 · AG · contact PI
Discovering Pathways of Functional Decline: A GWAS Approach$415,575
RC1 · FY2009 · AG
Age-related inflammatory changes: The role of genes and body composition changes$307,255
R01 · FY2008 · AG · contact PI
Age-related inflammatory changes: The role of genes and body composition changes$313,836
R01 · FY2007 · AG · contact PI
Age-related inflammatory changes: The role of genes and body composition changes$323,386
R01 · FY2006 · AG · contact PI